Molina, J. R., Grierson, P., Hecht, J. R., Patel, S. P., Simeone, D. M., Welling, T. H., Kirtane, K., Morelli, M. P., Kundranda, M. N., Maloney, D. G., Locke, F. L., Maus, M. V., Davila, M. L., Go, W. Y., Liechty, K. B., Bretzlaff, W., Mardiros, A., Hazim, A. Z., Ulrickson, M., Punekar, S. R. (2025). EVEREST-1: Safety and efficacy data of A2B530, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with solid tumors associated with carcinoembryonic antigen (CEA) expression and with human leukocyte antigen (HLA) loss of heterozygosity (LOH).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16408